Patent · US Active

Crystalline forms of compositions comprising psilocin and psilocybin

US11667607B1 · kind B1 · utility

1Cited by
0References
22Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 12, 2022
Grant dateJun 6, 2023
Priority date
Expiry dateSep 12, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure provides a composition comprising crystalline forms A, B, and C of psilocin and psilocybin. Solvent screen, X-ray powder diffractogram, thermogravimetric mass spectroscopy, differential scanning calorimetry, 1H-NMR, dynamic vapor sorption, and UPLC data on each of the crystalline forms is presented, along with methods preparing each of the crystalline forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.